Thread: Not good news
View Single Post
Old 07-30-2013, 07:21 AM
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
Default

Yes, we need to factor in age. But who has the data? Otherwise we need to adopt an indirect approach.

Lethbridge et al. looked at death certificates issued in Nova Scotia.

For PwP the main co-morbidities were:
Alzheimer's/dementia at 26.2%
Pneumonia, 22.3%
Stroke, 14.2%

Does this disprove the 80% figure after 8 years? Not quite. First, we have the issue of under-reporting: there may be a reluctance to report dementia. Second, we don't know what proportion of the people had had PD for at least 8 years before dying. A clue to this is given by Isihara et al. who report [2] "a Dutch study, ... median survival after PD diagnosis at 71 years or older was 9 years".

At this stage I get stuck. Can anyone progress this?

References

[1] Prog Palliat Care. 2013 July; 21(3): 140–145. .
doi: 10.1179/1743291X12Y.0000000037
PMCID: PMC3703207
"Co-morbidities of persons dying of Parkinson's disease"
Lynn Lethbridge, Grace M Johnston, and George Turnbull
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703207/

[2] J Neurol Neurosurg Psychiatry 2007;78:1304-1309 doi:10.1136/jnnp.2006.100107
"Estimated life expectancy of Parkinson’s patients compared with the UK population"
Lianna S Ishihara, Anne Cheesbrough, Carol Brayne1, Anette Schrag
http://jnnp.bmj.com/content/78/12/1304.full

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (07-31-2013)